Image de couverture de livre

c‐KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shubham C. Rivonker, Hossam Nada, Cho Jaemin, Yong‐Jun Kwon, Kyeong Lee
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Archiv der Pharmazie
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Designing Telomerase Inhibitors for Cancer Therapy: Mechanistic Insights, Medicinal Chemistry Strategies, Challenges, and Future Directions
par: Ahmed A. Al‐Karmalawy, et autres
Publié: (2026)

Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions
par: Anju Sheokand, et autres
Publié: (2025)

Therapeutic Horizons in Targeting EZH2 With Dual and Non‐PROTAC Inhibitor Molecules: Recent Achievements, Comparative Analysis, and Future Perspectives
par: Hamada S. Abulkhair
Publié: (2026)

NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives
par: Giada Cernicchi, et autres
Publié: (2025)

A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth
par: Joo Hyun Jung, et autres
Publié: (2024)

Exploring the SAR of 1,2,3‐Triazoles as Tumor‐Associated Carbonic Anhydrases IX and XII Inhibitors for Anticancer Applications
par: Naveen Chauhan, et autres
Publié: (2025)

Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
par: Enrico Mario Alessandro Fassi, et autres
Publié: (2025)

Erratum: Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
Publié: (2026)

Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential
par: Md Mustahidul Islam, et autres
Publié: (2025)

Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)
par: Neeru Malik, et autres
Publié: (2025)

An Insight Into Commercially Available SGLT2 Inhibitors and Their Structure–Activity Relationship Studies
par: Asiya Parveen, et autres
Publié: (2025)

Bruceantin and Brusatol: Molecular Insights and Therapeutic Promise of Quassinoids in Cancer Drug Discovery
par: Shumaila Ijaz, et autres
Publié: (2025)

Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease
par: Amira E. Shaaban, et autres
Publié: (2025)

Structural Advances in Non‐Sulfonamide Carbonic Anhydrase Inhibitors: Insights Into Design, Bioactivity, and Binding Mechanism
par: Mahmood Ahmed, et autres
Publié: (2025)

Isotretinoin as a Multifunctional Anticancer Agent: Molecular Mechanisms, Pharmacological Insights and Therapeutic Potential
par: Pritam Sarkar, et autres
Publié: (2025)

Emerging Coumestans in Cancer Therapy With Mechanistic Insights and Clinical Potential
par: MD Tameem Tabbasum, et autres
Publié: (2025)

A review of recent advances in anticancer activity and SAR of pyrazole derivatives
par: Heba A. Hofny, et autres
Publié: (2025)

Current Landscape of Indole Hybrids in the Design and Development of Anti‐Alzheimer Agents: Structural Insights, Therapeutic Potential and In Silico Studies
par: Akshad D. Bagul, et autres
Publié: (2026)

Discovery of Novel Autotaxin Inhibitors Bearing the 4,5,6,7‐Tetrahydro‐7 H ‐Pyrazolo[3,4‐ c ]Pyridine‐7‐One Core for Pulmonary Fibrosis Therapy
par: Jiahe Zhang, et autres
Publié: (2025)

The Therapeutic Potential of Berberine in Lung Cancer
par: Zohreh Jafari, et autres
Publié: (2025)

Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases
par: Andrea Ammara, et autres
Publié: (2025)

Exploration of Aromatic Hydrazides as Inhibitors of Human Carbonic Anhydrases
par: German Benito Menendez, et autres
Publié: (2025)

Novel Taurinamide‐Based Compounds as Carbonic Anhydrase Inhibitors
par: Ozlem Akgul, et autres
Publié: (2025)

AI/ML‐Driven DPP‐4 Inhibitor Predictor (d4p_v1) for Enhanced Type 2 Diabetes Mellitus Management: Insights Into Chemical Space, Fingerprints, and Electrostatic Potential Maps
par: Anu Manhas, et autres
Publié: (2025)

Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy
par: Yu Cao, et autres
Publié: (2025)

Benzoxaboroles Are Inhibitors of the η ‐Class Carbonic Anhydrase From Plasmodium falciparum
par: Alessandro Bonardi, et autres
Publié: (2026)

Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships
par: Sandipan Dash, et autres
Publié: (2025)

Design, synthesis, structure elucidation, antimicrobial, molecular docking, and SAR studies of novel urea derivatives bearing tricyclic aromatic hydrocarbon rings
par: Farid M. Sroor, et autres
Publié: (2024)

Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏
par: Hazem Elkady, et autres
Publié: (2025)

Erratum: Targeting the Isoprenoid Pathway in Choleste Biosynthesis: An Approach to Identify Isoprenoid Biosynthesis Inhibitors
Publié: (2025)

Combating Drug‐Resistant Protozoal Infections: A Review of Emerging Therapeutics
par: Anju A. Tom, et autres
Publié: (2025)

Current Scenario of Hydroxamic Acid Derivatives With In Vivo Antitumor Therapeutic Potential
par: Zhi Xu, et autres
Publié: (2025)

Exosomal lncRNAs in the Tumor Angiogenesis: As Therapeutic Targets in Cancer Treatment
par: Chou‐Yi Hsu, et autres
Publié: (2025)

Synthesis and Evaluation of Thiosemicarbazone Inhibitors for SARS‐CoV‐2 Mpro by Spectroscopy and Microscale Thermophoresis
par: Leyao Chen, et autres
Publié: (2025)

Fully Synthetic Non‐Carbohydrate Heparin Mimetics—Perspectives for Therapeutic Anticoagulation and Beyond?
par: Katrin Nekipelov, et autres
Publié: (2026)

Sequential Optimization Approach Toward an Azapeptide‐Based SARS‐CoV‐2 Main Protease Inhibitor
par: Rabea Voget, et autres
Publié: (2025)

Design, Synthesis and Antidiabetic Activity of Novel Pyrrole‐3‐Carboximidamide Derivatives as Dipeptidyl Peptidase‐4 Inhibitors
par: Hossein Fasihi Dastjerdi, et autres
Publié: (2025)

A Rofecoxib‐Derived Theranostic Probe and Its Combination With PD‐1 Inhibitor for High‐Efficiency Cancer Therapy
par: Xinli Wang, et autres
Publié: (2025)

New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti‐Tumor Activity Against Ewing Sarcoma
par: Caroline de Bem Gentz, et autres
Publié: (2026)

Harnessing Hybrid Chemistry: Novel Ethyl Ferulate Ester of Niflumic Acid for Enhanced Therapeutic Benefits
par: Rahila P. Chavilkad, et autres
Publié: (2026)